BioStock: Arcede Pharma looks ahead with strengthened team

On Monday, Arcede Pharma released its report for the third quarter of the shortened fiscal year 2022. While waiting to start the final part of the toxicology program, two leading experts in the respiratory field have joined the company as advisors. BioStock contacted CEO Mia Lundblad to find out more.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/02/arcede-pharma-looks-ahead-with-strengthened-team/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se